Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Etripamil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Milestone Pharma To Showcase Etripamil Data At AHA 2025
    Milestone Pharma To Showcase Etripamil Data At AHA 2025

    09 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/09/3164056/0/en/Milestone-Pharmaceuticals-to-Present-Data-on-Etripamil-at-the-American-Heart-Association-Scientific-Sessions-2025.html

    GLOBENEWSWIRE
    09 Oct 2025
    Share Share
    Milestone Pharma's Response to CARDAMYST CRL Accepted by FDA
    Milestone Pharma's Response to CARDAMYST CRL Accepted by FDA

    11 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/11/3113902/0/en/Milestone-Pharmaceuticals-Announces-FDA-Acceptance-of-the-Company-s-Response-to-the-CRL-for-CARDAMYST-etripamil-Nasal-Spray.html

    GLOBENEWSWIRE
    11 Jul 2025
    Share Share
    FDA declines to approve Milestone's heart rhythm nasal spray
    FDA declines to approve Milestone's heart rhythm nasal spray

    29 Mar 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-milestone-pharmas-heart-rhythm-nasal-spray-2025-03-28/

    REUTERS
    29 Mar 2025
    Share Share
    FDA Issues Complete Response Letter for Etripamil for PSVT
    FDA Issues Complete Response Letter for Etripamil for PSVT

    28 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/28/3051260/0/en/FDA-Issues-Complete-Response-Letter-for-Etripamil-for-PSVT.html

    GLOBENEWSWIRE
    28 Mar 2025
    Share Share
    Milestone Pharmaceuticals to Present Etripamil Data at ACC
    Milestone Pharmaceuticals to Present Etripamil Data at ACC

    20 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/20/3046176/0/en/Milestone-Pharmaceuticals-to-Present-Clinical-Data-on-Etripamil-at-the-American-College-of-Cardiology.html

    GLOBENEWSWIRE
    20 Mar 2025
    Share Share
    Milestone Pharma Notice of Allowance on New Patent for Etripamil
    Milestone Pharma Notice of Allowance on New Patent for Etripamil

    19 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/02/19/3028736/0/en/Milestone-Pharmaceuticals-Notice-of-Allowance-on-New-U-S-Patent-for-Etripamil.html

    GLOBENEWSWIRE
    19 Feb 2025
    Share Share